About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID 		TgTn(sb-T2/Onc2)6070Njen
transgenic transposon concatemer 6070, Nancy A Jenkins
MGI:3613048
Summary 4 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
 		Aicdatm1(cre)Mnz/Aicda+
Gt(ROSA)26Sortm2(sb11)Njen/Gt(ROSA)26Sor+
TgTn(sb-T2/Onc2)6070Njen/0 		involves: 129 * 129P2/OlaHsd * C57BL/6 * C57BL/6J MGI:4367198
cn2
 		Gt(ROSA)26Sortm2(sb11)Njen/Gt(ROSA)26Sor+
TgTn(sb-T2/Onc2)6070Njen/0 		involves: 129 * C57BL/6 * C57BL/6J MGI:4367197
cn3
 		Gt(ROSA)26Sortm2.1(sb11)Njen/Gt(ROSA)26Sor+
TgTn(sb-T2/Onc2)6070Njen/0 		involves: 129 * C57BL/6 * C57BL/6J MGI:4367199
cn4
 		Gt(ROSA)26Sortm1(sb11)Njen/Gt(ROSA)26Sor+
TgTn(sb-T2/Onc2)6070Njen/0 		involves: C3H * C57BL/6 MGI:3613060


Genotype
MGI:4367198
cn1
Allelic
Composition		 Aicdatm1(cre)Mnz/Aicda+
Gt(ROSA)26Sortm2(sb11)Njen/Gt(ROSA)26Sor+
TgTn(sb-T2/Onc2)6070Njen/0
Genetic
Background		 involves: 129 * 129P2/OlaHsd * C57BL/6 * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Aicdatm1(cre)Mnz mutation (1 available); any Aicda mutation (57 available)
Gt(ROSA)26Sortm2(sb11)Njen mutation (7 available); any Gt(ROSA)26Sor mutation (993 available)
TgTn(sb-T2/Onc2)6070Njen mutation (2 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
mortality/aging
premature death ( J:153656 )
• compared with Gt(ROSA)26Sortm2(sb11)Njen TgTn(sb-T2/Onc2)6070Njen mice

neoplasm
increased tumor incidence ( J:153656 )
• greater than 90% of moribund mice develop tumors with an average latency of 46 weeks
increased hemolymphoid system tumor incidence ( J:153656 )
• mice develop hematopoietic tumors including B cell, T cell, and myeloid tumors unlike Gt(ROSA)26Sortm2(sb11)Njen TgTn(sb-T2/Onc2)6070Njen mice that do not develop tumors
increased T cell derived lymphoma incidence ( J:153656 )
• 3 T cell lymphomas develop
increased leukemia incidence ( J:153656 )
• 2 myeloid leukemia tumors develop
increased B cell derived lymphoma incidence ( J:153656 )
• mice develop B cell lymphomas including diffuse large cell lymphomas and follicular lymphomas
• one mouse developed pre-B lymphoma

integument

nervous system

endocrine/exocrine glands
increased T cell derived lymphoma incidence ( J:153656 )
• 3 T cell lymphomas develop

immune system
increased T cell derived lymphoma incidence ( J:153656 )
• 3 T cell lymphomas develop

hematopoietic system
increased T cell derived lymphoma incidence ( J:153656 )
• 3 T cell lymphomas develop




Genotype
MGI:4367197
cn2
Allelic
Composition		 Gt(ROSA)26Sortm2(sb11)Njen/Gt(ROSA)26Sor+
TgTn(sb-T2/Onc2)6070Njen/0
Genetic
Background		 involves: 129 * C57BL/6 * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm2(sb11)Njen mutation (7 available); any Gt(ROSA)26Sor mutation (993 available)
TgTn(sb-T2/Onc2)6070Njen mutation (2 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
immune system
increased susceptibility to infection ( J:153656 )
• 2 mice develop urinary tract infections

liver/biliary system
liver cirrhosis ( J:153656 )
• in one mouse

muscle
muscle degeneration ( J:153656 )
• one mouse exhibited myocyte degeneration

integument
abnormal skin condition ( J:153656 )
• one mouse exhibited skin irritation




Genotype
MGI:4367199
cn3
Allelic
Composition		 Gt(ROSA)26Sortm2.1(sb11)Njen/Gt(ROSA)26Sor+
TgTn(sb-T2/Onc2)6070Njen/0
Genetic
Background		 involves: 129 * C57BL/6 * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm2.1(sb11)Njen mutation (0 available); any Gt(ROSA)26Sor mutation (993 available)
TgTn(sb-T2/Onc2)6070Njen mutation (2 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
mortality/aging
premature death ( J:153656 )
• compared with Gt(ROSA)26Sortm2(sb11)Njen TgTn(sb-T2/Onc2)6070Njen and Gt(ROSA)26Sortm2(sb11)Njen Aicdatm1(cre)Mnz TgTn(sb-T2/Onc2)6070Njen mice

neoplasm
increased hemolymphoid system tumor incidence ( J:153656 )
• mice develop hematopoietic tumors including T cell and erythoid tumors
• tumor latency is 59 days
increased T cell derived lymphoma incidence ( J:153656 )
• 67% of tumors are T cell lymphomas
increased leukemia incidence ( J:153656 )
• one mouse exhibited erythroid leukemia

endocrine/exocrine glands
increased T cell derived lymphoma incidence ( J:153656 )
• 67% of tumors are T cell lymphomas

hematopoietic system
increased T cell derived lymphoma incidence ( J:153656 )
• 67% of tumors are T cell lymphomas

immune system
increased T cell derived lymphoma incidence ( J:153656 )
• 67% of tumors are T cell lymphomas




Genotype
MGI:3613060
cn4
Allelic
Composition		 Gt(ROSA)26Sortm1(sb11)Njen/Gt(ROSA)26Sor+
TgTn(sb-T2/Onc2)6070Njen/0
Genetic
Background		 involves: C3H * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1(sb11)Njen mutation (1 available); any Gt(ROSA)26Sor mutation (993 available)
TgTn(sb-T2/Onc2)6070Njen mutation (2 available)
♀ phenotype observed in females
♂ phenotype observed in males
N normal phenotype
mortality/aging
premature death ( J:102234 )
• all mice that survive past weaning die by 17 weeks of age from cancer
lethality throughout fetal growth and development, incomplete penetrance ( J:102234 )
• only 12.5% (17 of 136) of pups at birth are double mutants and significant loss of these mice is seen at E16 but not at E10

neoplasm
increased tumor incidence ( J:102234 )
• all double mutants develop cancer with a variety of tumor types
increased lymphoma incidence ( J:102234 )
• non-T/non-B cell derived lymphoma is also seen
increased T cell derived lymphoma incidence ( J:102234 )
• most common type of tumor
increased medulloblastoma incidence ( J:102234 )
• some mice develop medulloblastomas

embryo
decreased embryo size ( J:102234 )
• at E10 and E16, many embryos appear smaller than control littermates

digestive/alimentary system
abnormal duodenum morphology ( J:102234 )
• hyperplasia of the duodenum was seen in 2 mice

growth/size/body
decreased embryo size ( J:102234 )
• at E10 and E16, many embryos appear smaller than control littermates
decreased fetal size ( J:102234 )
• at E16

endocrine/exocrine glands
increased T cell derived lymphoma incidence ( J:102234 )
• most common type of tumor

nervous system
increased medulloblastoma incidence ( J:102234 )
• some mice develop medulloblastomas

immune system
increased T cell derived lymphoma incidence ( J:102234 )
• most common type of tumor

hematopoietic system
increased T cell derived lymphoma incidence ( J:102234 )
• most common type of tumor




Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
12/10/2024
MGI 6.24 		The Jackson Laboratory